Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SYK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
A gene referenced in 1 knowledge graph relationship. Key connections: encodes SYK_kinase (protein).
No AI portrait yet
| Gene Symbol | SYK |
| Chromosome | 9q22 |
| Protein Family | Src family tyrosine kinases |
| Protein Type | Receptor |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Primary Expression | brain microglia (Iba1+ cells) - Increased expression in disease states - Localizes to amyloid plaques in AD |
| Molecular Weight | 72 kDa |
| Amino Acids | 629 aa |
| Exons | 18 |
| Pathways | PI3K, MAPK |
| UniProt ID | P43405 |
| NCBI Gene ID | 6715 |
| GeneCards | SYK |
| Human Protein Atlas | SYK |
| Associated Diseases | ALS, Alzheimer, CYTOKINES, PYROPTOSIS |
| Known Drugs/Compounds | Entospletinib, metformin, Pustulan, R406 |
| Interactions | AIM2, AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, AND |
| KG Connections | 361 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
SYK["SYK"]
Alzheimer{"Alzheimer"}
SYK -->|"activates"| Alzheimer
Ms{"Ms"}
SYK -->|"activates"| Ms
SYK -->|"associated with"| Alzheimer
TFEB["TFEB"]
SYK -->|"associated with"| TFEB
TREM2["TREM2"]
SYK -->|"associated with"| TREM2
Als{"Als"}
SYK -->|"interacts with"| Als
Obesity{"Obesity"}
SYK -->|"activates"| Obesity
Depression{"Depression"}
SYK -->|"expressed in"| Depression
SYK -->|"activates"| TREM2
Apoptosis(["Apoptosis"])
SYK -->|"activates"| Apoptosis
Amyloid(["Amyloid"])
SYK -->|"associated with"| Amyloid
SYK -->|"associated with"| Apoptosis
AKT["AKT"]
AKT -->|"associated with"| SYK
PI3K["PI3K"]
PI3K -->|"associated with"| SYK
APOE["APOE"]
APOE -->|"associated with"| SYK
MICROGLIA["MICROGLIA"]
MICROGLIA -->|"activates"| SYK
TREM2 -->|"expressed in"| SYK
IL6["IL6"]
IL6 -->|"expressed in"| SYK
IL1B["IL1B"]
IL1B -->|"expressed in"| SYK
IL10["IL10"]
IL10 -->|"expressed in"| SYK
TAU["TAU"]
TAU -->|"expressed in"| SYK
APOPTOSIS["APOPTOSIS"]
APOPTOSIS -->|"activates"| SYK
AMYLOID["AMYLOID"]
AMYLOID -->|"activates"| SYK
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
ALZHEIMER_S_DISEASE -->|"activates"| SYK
style SYK fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| PI3K/AKT/mTOR | regulates | pathway | 0.95 |
| Tau Phosphorylation | regulates | process | 0.95 |
| HIF-1α/c-Myc | regulates | pathway | 0.95 |
| macrophage phagocytosis | regulates | process | 0.95 |
| Macrophage Phagocytosis | regulates | process | 0.95 |
| Functional Recovery After Spinal Cord Injury | promotes | phenotype | 0.95 |
| Monocyte-Derived Macrophages | expressed_in | cell_type | 0.95 |
| Spinal Cord Injury | therapeutic_target | disease | 0.93 |
| axonal regeneration | promotes | process | 0.90 |
| acute motor axonal neuropathy | therapeutic_target | disease | 0.90 |
| AMPK/STAT3 | regulates | pathway | 0.90 |
| PI3K/AKT pathway | activates | pathway | 0.90 |
| Microglia | associated_with | cell_type | 0.90 |
| lipid metabolism | modulates | pathway | 0.90 |
| mitophagy | modulates | process | 0.90 |
| Tau Oligomerization | regulates | process | 0.90 |
| PI3K/Akt/mTOR pathway | activates | pathway | 0.90 |
| locomotor recovery | promotes | phenotype | 0.89 |
| lipid droplet accumulation | regulates | phenotype | 0.87 |
| CSF1R | cooperates_with | gene | 0.85 |
| PLCG2 | phosphorylates | gene | 0.85 |
| Axonal Regrowth | promotes | process | 0.85 |
| Aβ Clearance | associated_with | process | 0.80 |
| CD22 Blockade | mediates | drug | 0.80 |
| Alzheimer's Disease | involved_in | disease | 0.80 |
| Amyloid-Beta Clearance | associated_with | process | 0.75 |
| Inflammation | therapeutic_target | disease | 0.75 |
| oxidative stress response | participates_in | pathway | 0.75 |
| pyroptosis | participates_in | pathway | 0.70 |
| PI3K/AKT/MTOR | causes | pathway | 0.70 |
| MICROGLIA | protects_against | cell_type | 0.70 |
| PI3K/AKT PATHWAY | causes | pathway | 0.70 |
| Neurodegeneration | regulates | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Stroke | inhibits | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Neuroinflammation | regulates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| PYROPTOSIS | causes | phenotype | 0.65 |
| MTOR | transports | gene | 0.65 |
| HIPPOCAMPUS | inhibits | brain_region | 0.65 |
| PYROPTOSIS | treats | phenotype | 0.65 |
| OXIDATIVE STRESS | activates | phenotype | 0.65 |
| AUTOPHAGY | activates | phenotype | 0.65 |
| CYTOKINES | inhibits | phenotype | 0.65 |
| CYTOKINES | causes | phenotype | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Entospletinib | inhibits | drug | 0.95 |
| TREM2 | interacts_with | gene | 0.92 |
| h-trem2-f3effd21 | targets_gene | hypothesis | 0.90 |
| Pustulan | activates | compound | 0.90 |
| h-d2937ed0 | targets | hypothesis | 0.90 |
| TYROBP | activates | gene | 0.90 |
| TREM2 | upstream_of | gene | 0.88 |
| R406 | inhibits | drug | 0.85 |
| CD22 Blockade | phosphorylates | drug | 0.85 |
| TYROBP | recruits_and_activates | gene | 0.85 |
| CLEC7A | activates | gene | 0.80 |
| INFLAMMATION | therapeutic_target | gene | 0.70 |
| APOE | interacts_with | gene | 0.70 |
| APOE | phosphorylates | gene | 0.70 |
| TYROBP | phosphorylates | gene | 0.70 |
| TYROBP | interacts_with | gene | 0.70 |
| CSF | activates | phenotype | 0.65 |
| CSF | interacts_with | phenotype | 0.65 |
| VCP | phosphorylates | gene | 0.65 |
| NLRP3 | mediates | gene | 0.65 |
| TYROBP | regulates | gene | 0.65 |
| TREM2 | mediates | gene | 0.65 |
| TREM2 | inhibits | gene | 0.65 |
| NLRP3 INFLAMMASOME | degrades | pathway | 0.65 |
| NLRP3 INFLAMMASOME | regulates | pathway | 0.65 |
| DAM | activates | cell_type | 0.65 |
| DAM | interacts_with | cell_type | 0.65 |
| MICROGLIA | causes | cell_type | 0.65 |
| APOE | associated_with | gene | 0.65 |
| MICROGLIA | associated_with | cell_type | 0.65 |
| ISCHEMIA | regulates | disease | 0.65 |
| PYROPTOSIS | regulates | phenotype | 0.65 |
| AKT | associated_with | gene | 0.65 |
| PI3K | associated_with | gene | 0.65 |
| FERROPTOSIS | inhibits | phenotype | 0.65 |
| MACROPHAGE | activates | cell_type | 0.65 |
| VCP | regulates | gene | 0.65 |
| JAK1 | regulates | gene | 0.60 |
| KEAP1 | regulates | gene | 0.60 |
| RIPK3 | regulates | gene | 0.60 |
| STING | regulates | gene | 0.60 |
| CX3CR1 | co_discussed | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| AKT | inhibits | gene | 0.60 |
| CXCL1 | activates | gene | 0.60 |
| NLRP3 | expressed_in | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| IL-18 | activates | gene | 0.60 |
| NLRP3 | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Microglial TREM2-SYK Pathway Enhancement | 0.798 | neurodegeneration | Cell type vulnerability in Alzheimers Di |
| αvβ3 Integrin-FAK-SYK-CARD9/NF-κB Pathway | 0.580 | neuroinflammation | What molecular mechanisms mediate SPP1-i |
| SYK-Independent TREM2 Pathways Remain Functional in TYROBP D | 0.548 | neuroinflammation | Why is TYROBP deficiency neuroprotective |
| TYROBP-SYK Pathway Enhancement | 0.480 | neurodegeneration | TREM2 Therapeutic Strategy Post-INVOKE-2 |
| TREM2-SYK Signaling Axis Couples OxPC Recognition to Phagocy | 0.453 | neuroinflammation | What molecular mechanisms enable microgl |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861
neurodegeneration | 2026-04-11 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 1 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurod [PMID:33603230] | Dong Y, D'Mello C, Pinsky W, Lozinski BM | Nature neuroscience | 2021 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 4 · Score: 0.50 · 2026-04-27
closed · Rounds: 4 · Score: 0.64 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.92 · 2026-04-26
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
Hypotheses and analyses mentioning SYK in their description or question text
No additional research found